Search
Search your stock
Analysis
Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc. (BMEA)
Ranking:
Sell
Implies negative momentum
Stock Name: Biomea Fusion, Inc.
Symbol: BMEA
Market Cap: $237M
Industry: Biotechnology
Sector: Healthcare
Website: https://biomeafusion.com
About Biomea Fusion, Inc.

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California. Please visit their website for more information.

Overview:
Last Close: $6.53
52 Week: $4.14-$19.80
MVA50: 9.07
MVA200: 10.20
RSI: 25.56
Buy/Sell*: 21.04
1-Month change: -59.72%
3-Month change: 18.99%
*Proprietary Buy Sell Volume Indicator
Price Chart For BMEA
Financial Parameters Most Recent Quarter: (2024-Q3),2024-09-30
Revenue: $0M
Revenue Growth (YOY): nan%
Profit (% of Rev): -inf%
Income (% of Rev): -inf%
Income Growth (YOY): 15.33%
Operating Income: $-34M
Operating Cash Flow: $-25M
Operating Cash Flow Growth (YoY): 5.51%
Annual Dividend Yield: 0.00%
Total Assets: $110M
Total Liabilities: $34M
Cash & Equivalent: $88M
Total Debt: $10M
Debt/Equity: 0.04
Quick Ratio: 3.39
Current Ratio: 3.39
Price/Book: 4.82
Price/Earnings: -2.79
EBITDA: $-34M
EPS: -0.91
Our Approach

Our proprietary analysis employs a weighted average approach integrating both functional and technical parameters, tailored to the sector, industry, and microeconomic factors. This methodology assigns dynamic weights to the parameters, with a focus on recent trends, ensuring a nuanced evaluation for informed investment decisions. Considering all the above parameters, in addition to some of the derived parameters of the stock in conjunction with its sector and macroeconomic conditions, our proprietary Weighted Average AI model gives a rank of Sell.

TheoryofStocks is not registered as an investment advisor with any regulatory authority. The information provided on this Website is for educational purposes only and should not be construed as financial or investment advice. By continuing to use this site, you are agreeing to the Terms of Use and Privacy Policy. Please read our Disclaimer.

Contact @ support@theoryofstocks.com

© 2024 Stock Articles. All rights reserved.

This site uses cookies to ensure the best experience. By continuing to use this site, you agree to their use.

Click here for Cookie Policy